eShop USA > Books > Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.(Clinical ... from: Journal of Drugs in Dermatology
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.(Clinical ... from: Journal of Drugs in Dermatology
Our Price: $9.95 Prices subject to change. 1 Thirdparty New from $9.95
Availability: Available for download now
Binding: Digital
Format: HTML
Label: Thomson Gale
Manufacturer: Thomson Gale
Number Of Pages: 18
Publication Date: June 01, 2007
Publisher: Thomson Gale
Release Date: June 27, 2007
Studio: Thomson Gale
Editorial Review:
This digital document is an article from Journal of Drugs in Dermatology, published by Thomson Gale on June 1, 2007. The length of the article is 5146 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation Details
Title: Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.(Clinical report)
Author: Joel Schlessinger
Publication: Journal of Drugs in Dermatology (Magazine/Journal)
Date: June 1, 2007
Publisher: Thomson Gale
Volume: 6 Issue: 6 Page: 607(9)Article Type: Clinical reportDistributed by Thomson Gale
Related Categories:
| |
 |
